[Advances in Surgical Treatment Following Conversion Therapy for Pancreatic Cancer]. [PDF]
Meng L, Li Y, Peng B.
europepmc +1 more source
[Emphasizing Principles of Surgical Oncology in Minimally Invasive Surgery for Pancreatic Cancer]. [PDF]
Gou S, Wu H.
europepmc +1 more source
microRNA25、CA199联合CT 在胰腺癌诊断及预后中的价值分析 附视频
目的 分析沉默微小RNA-25(microRNA25)、糖类抗原199(Carbohydrate antigen199,CA199)联合电子计算机断层扫描(Computer Tomography, CT)在胰腺癌诊断及预后中的价值。方法 选取2019年6月至2022年6月中国中医科学院广安门医院收治的215例疑似胰腺癌患者为研究对象,对患者进行CT检查,确诊为胰腺癌的110例患者为观察组,剩余105例非胰腺癌者为对照组。结果 与对照组相比,观察组CT参数血流量(blood flow, BF)、血流血容量(
doaj +2 more sources
本文介绍了淋巴因子活化的杀伤细胞(LAK细胞),在YPC3抗人胰腺癌单克隆抗体(YPC3mAb)的介导下,对体外、体内人胰腺癌细胞生长的影响。体外4h51Cr释放试验表明,特异性识别Capan-2人胰腺癌细胞的YPC3mAb能通过抗体依赖性细胞介导的细胞毒作用(ADCC)显著增强LAK细胞对Capan-2细胞的杀伤作用,这种作用随mAb的浓度增加而加强,50μg/ml的YPC3mAb提高LAK细胞杀伤率约60%。对照mAb无此作用。裸鼠体内实验发现,YPC3mAb与LAK细胞联合应用能完全阻止Capan-
doaj
[Low-intensity pulsed ultrasound and oridonin synergistically induce ferroptosis of pancreatic cancer cells by activating PIEZO1 <i>via</i> the Nrf2/HO-1/GPX4 pathway]. [PDF]
Sun B +5 more
europepmc +1 more source
胰腺癌的肿瘤标志物张太平赵玉沛作者单位:100730北京,中国医学科学院北京协和医院外科胰腺癌发病率近年来在全球呈上升趋势,总的五年生存率仅3%。改善胰腺癌患者生存状况的关键是提高早期诊断水平,研究更加有效的筛选技术。虽然近年来影像学诊断有了较大进展...
doaj
[Enhanced tumoricidal activity of PD-1 antibody-secreting c-Met CAR-T cells against pancreatic cancer cells]. [PDF]
Min J +7 more
europepmc +1 more source
目的应用生物信息学的方法探讨趋化素样因子超家族成员(chemokine-like factor-like MARVEL transmembrane domain containing member/chemokine-like factor superfamily member,CMTM/CKLFSF,CMTM)在胰腺癌中异常表达的临床病理特征,并分析相关基因共表达的意义。方法通过GEPIA2、HPA和Kaplan-Meier plotter数据库分析CMTM家族成员在胰腺癌中的表达和预后价值 ...
黄冠宁 +5 more
doaj +2 more sources
Mass spectrometry analysis of intact protein N-glycosylation signatures of cells and sera in pancreatic adenocarcinomas. [PDF]
Xu M +11 more
europepmc +1 more source
[Therapeutic mechanism of aqueous extract of Semiliquidambar cathayensis Chang root for pancreatic cancer: the active components, therapeutic targets and pathways]. [PDF]
Huang Y +8 more
europepmc +1 more source

